Low dose of wortmannin reduces radiosensitivity of human glioblastoma cells through the p53 pathway

Oncol Rep. 2002 Jul-Aug;9(4):859-62.

Abstract

Wortmannin is an inhibitor of PI3-kinase and acts on cultured cells at dosages below 1 microM. Wortmannin also inhibits the gene products of the PI3-kinase family such as ATM or DNA-PK at dosages above 10 microM in cultured cells. There are many reports on the enhancement of radiosensitivity by a high dose of wortmannin inhibiting the proteins of the PI3-kinase family. However, there have been no reports on the effect on radiosensitivity of low doses of wortmannin inhibiting PI3-kinase. We found that low doses of wortmannin reduced the radiosensitivity of human A172 glioblastoma cells. This effect was shown only in wild-type p53 cells, but was not shown in mutant p53 cells such as T98G or A172/248W carrying a dominant point-mutated p53 gene. This result indicates that the PI3-kinase, or another wortmannin-sensitive enzyme, may affect the signal transduction of p53. We examined the response of the p53 pathway by X-ray irradiation. A low dose of wortmannin did not affect the accumulation of p53 and the phosphorylation of p53 at ser-15, but reduced the induction of WAF1 and enhanced the induction of GADD45.

MeSH terms

  • Androstadienes / pharmacology*
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / metabolism
  • Brain Neoplasms / radiotherapy
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins / metabolism
  • Dose-Response Relationship, Radiation
  • Enzyme Inhibitors / pharmacology*
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / radiation effects
  • Glioblastoma / drug therapy
  • Glioblastoma / metabolism
  • Glioblastoma / radiotherapy
  • Humans
  • Phosphoinositide-3 Kinase Inhibitors*
  • Radiation Tolerance*
  • Radiation-Sensitizing Agents / pharmacology*
  • Signal Transduction
  • Tumor Cells, Cultured / drug effects*
  • Tumor Cells, Cultured / metabolism
  • Tumor Cells, Cultured / radiation effects*
  • Tumor Suppressor Protein p53 / metabolism*
  • Wortmannin
  • X-Rays / adverse effects

Substances

  • Androstadienes
  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • Enzyme Inhibitors
  • Phosphoinositide-3 Kinase Inhibitors
  • Radiation-Sensitizing Agents
  • Tumor Suppressor Protein p53
  • Wortmannin